{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:38:04Z","timestamp":1794274684607,"version":"4.9.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21645515.2025.2532272","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T12:37:27Z","timestamp":1752237447000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Willingness among adults in the United States to receive a combination influenza and COVID-19 vaccine"],"prefix":"10.1080","volume":"21","author":[{"given":"Riley J.","family":"Summers","sequence":"first","affiliation":[{"name":"The Ohio State University","place":["Columbus, USA"]},{"name":"The Ohio State University","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira L.","family":"Katz","sequence":"additional","affiliation":[{"name":"The Ohio State University","place":["Columbus, USA"]},{"name":"The Ohio State University","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-2600","authenticated-orcid":false,"given":"Paul L.","family":"Reiter","sequence":"additional","affiliation":[{"name":"The Ohio State University","place":["Columbus, USA"]},{"name":"The Ohio State University","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"Centers for Disease Control and Prevention. About estimated flu burden. 2024. https:\/\/www.cdc.gov\/flu-burden\/php\/about\/index.html."},{"key":"e_1_3_4_3_1","unstructured":"World Health Organization. Coronavirus disease (COVID-19) pandemic. 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"e_1_3_4_4_1","unstructured":"Worldometer. Coronavirus tracker. 2024. https:\/\/www.worldometers.info\/coronavirus\/country\/us\/#google_vignette."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7305a1"},{"key":"e_1_3_4_6_1","unstructured":"Immunize.org. Vaccine history timeline. 2025. https:\/\/www.immunize.org\/vaccines\/vaccine-timeline\/."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7337e2"},{"key":"e_1_3_4_8_1","article-title":"Revised recommendations for COVID-19 vaccines \u2013 U.S. vaccination policy under threat","author":"Schwartz JL","unstructured":"Schwartz JL. Revised recommendations for COVID-19 vaccines \u2013 U.S. vaccination policy under threat. N Engl J Med. In press. https:\/\/pubmed.ncbi.nlm.nih.gov\/40532168\/.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_9_1","unstructured":"Centers for Disease Control and Prevention. Getting a flu vaccine and other recommended vaccines at the same time. 2024. https:\/\/www.cdc.gov\/flu\/vaccines\/coadministration.html."},{"key":"e_1_3_4_10_1","unstructured":"Centers for Disease Control and Prevention. Respiratory illnesses: vaccination trends. 2025. https:\/\/www.cdc.gov\/respiratory-viruses\/data\/vaccination-trends.html."},{"key":"e_1_3_4_11_1","unstructured":"Centers for Disease Control and Prevention. ACIP recommendations: diphtheria tetanus and pertussis (DTaP\/tdap\/td) vaccines. 2024. https:\/\/www.cdc.gov\/acip-recs\/hcp\/vaccine-specific\/dtap-tdap-td.html."},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030322"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.7370"},{"key":"e_1_3_4_14_1","unstructured":"Sanofi. Press release: two combination vaccine candidates for prevention of influenza and COVID-19 granted fast track designation in the US. 2024. https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2024\/2024-12-11-06-00-00-2995072."},{"key":"e_1_3_4_15_1","unstructured":"Pfizer. Pfizer and BioNTech receive U.S. FDA fast track designation for single-dose mRNA-based vaccine candidate against COVID-19 and influenza. 2022. https:\/\/www.pfizer.com\/news\/announcements\/pfizer-and-biontech-receive-us-fda-fast-track-designation-single-dose-mrna-based."},{"key":"e_1_3_4_16_1","unstructured":"Novavax I.U.S. FDA removes clinical hold on Novavax\u2019s COVID-19-influenza combination and stand-alone influenza phase 3 trial. 2024. https:\/\/ir.novavax.com\/press-releases\/2024-11-11-U-S-FDA-Removes-Clinical-Hold-on-Novavaxs-COVID-19-Influenza-Combination-and-Stand-alone-Influenza-Phase-3-Trial#:~:text=U.S.%20FDA%20Removes%20Clinical%20Hold 3%20Trial%20%2D%20Nov%2011%2C%202024."},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.11.097"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.14811"},{"key":"e_1_3_4_19_1","unstructured":"ClinicalTrials.gov. Study of a combination vaccine comprised of different recombinant spike antigen levels of a matrix-M adjuvanted recombinant COVID-19 vaccine and recombinant influenza vaccine in adult participants 50 years of age and older (NCT06695130). 2025. https:\/\/clinicaltrials.gov\/study\/NCT06695130."},{"key":"e_1_3_4_20_1","unstructured":"ClinicalTrials.gov. Study of a combination vaccine comprised of different recombinant spike antigen levels of a matrix-M adjuvanted recombinant COVID-19 vaccine and high-dose inactivated influenza vaccine in adult participants 50 years of age and older (NCT06695117). 2025. https:\/\/clinicaltrials.gov\/study\/NCT06695117."},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181bf542c"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.043"},{"key":"e_1_3_4_23_1","unstructured":"U.S. Department of Agriculture. Rural-urban commuting area codes. 2020. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-7-21"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1884476"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/10810730.2023.2282036"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.2196\/42227"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.05.033"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.1.13500"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.05.013"},{"key":"e_1_3_4_31_1","unstructured":"World Health Organization. Ten threats to global health in 2019. 2019. https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019."},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129121"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002578"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/17538068.2016.1235531"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076542"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111832"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2016.11.016"},{"key":"e_1_3_4_38_1","first-page":"153","volume-title":"Social psychophysiology: a source book","author":"Rogers RW","year":"1983","unstructured":"Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo J, Petty R, editors. Social psychophysiology: a source book. New York: Guilford Press; 1983. p. 153\u2013176."},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/109019817400200407"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.107"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2007.05.013"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040816"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2207442"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2017.12.007"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2532272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2025.2532272","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2025.2532272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:46:15Z","timestamp":1786034775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2025.2532272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21645515.2025.2532272"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2025.2532272","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2532272"}}